Chronic Co-administration of Methylphenidate and Fluoxetine Reduces Striatal NMDA Receptor Binding in Adolescent Rats
Neurochemical Research · 2026-04 · 51 (2)
DOI: 10.1007/s11064-026-04743-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemical Research, online erschienen am 03.04.2026. Verfasst von George Lagamjis und 9 weiteren Autor:innen. Beteiligte Einrichtung: Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Clinical Research Institute on Addictions, Department of Pharmacology and Tox…. Hauptthemen laut MEDLINE: Receptors, N-Methyl-D-Aspartate, Methylphenidate, Fluoxetine, Corpus Striatum. Die Arbeit nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Foundation for the State University of New York.
Abstract (Originalsprache)
Methylphenidate (MP), a widely used medicine for attention deficit/hyperactivity disorder (ADHD), is commonly prescribed in combination with selective serotonin reuptake inhibitors (SSRI) e.g., fluoxetine (FLX). However, neurochemical effects of the MP + FLX combination have not been sufficiently elucidated. Given the pivotal role played by glutamatergic signaling in psychostimulant responses and corticostriatal plasticity, we employed a 2-level factorial design to assess how the individual treatments and their co-administration affect N-methyl-D-aspartate receptor (NMDAR) binding using [³H] MK-801 in vitro autoradiography. Three-week-old male rats were randomized into four groups: MP (30/60 mg/kg), FLX (20 mg/kg), MP + FLX (30/60 mg/kg and 20 mg/kg), and vehicle. Treatment was administered for four weeks using a dual bottle drinking paradigm that models human dosing and pharmacokinetics. Following the treatment, [³H] MK-801 in vitro autoradiography was performed on coronal brain sections. The MP + FLX group significantly decreased NMDA binding levels in the dorsal caudate-putamen (DCPU) (39%), ventral caudate-putamen (VCPU) (36%), and nucleus accumbens (Nac) (34%), compared to vehicle. Rats in the MP group demonstrated reduced NMDA binding in the DCPU only, and there were no significant differences in binding for the FLX group. These findings indicate that MP + FLX coadministration yields a reduction in NMDAR binding across the striatum, an effect not produced by either of the drugs. Thus, reduced NMDA binding following MP + FLX treatment may contribute to dysregulations in memory, motor, and reward systems. Further studies are warranted to evaluate the neurochemical, neurodevelopmental, and clinical correlates of MP + FLX glutamatergic effects in adolescent patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University…
- D'Amore-McKim School of Business, Northeastern University, Boston, MA, USA.
- Department of Psychiatry, Cambridge Health Alliance, Harvard Medical School, Boston, MA, USA.
- Department of Biological and Chemical Sciences, New York Institute of Technology, Westbury, NY, 11568, USA.
- Department of Orthopaedics and Rehabilitation, Stony Brook University, Stony Brook, NY, 11794, USA.
- Department of Psychology, State University of New York at Buffalo, Buffalo, NY, USA. thanos@buffalo.edu.
Förderung
- Research Foundation for the State University of New York
Zitieren
APA
Lagamjis, G., Slayton, D., Lu, H., Hoerner, C., Lantry, A. M., Marion, M., Elman, D., Hadjiargyrou, M., Komatsu, D., & Thanos, P. K. (2026). Chronic Co-administration of Methylphenidate and Fluoxetine Reduces Striatal NMDA Receptor Binding in Adolescent Rats. Neurochemical Research, 51(2). https://doi.org/10.1007/s11064-026-04743-5
Vancouver
Lagamjis G, Slayton D, Lu H, Hoerner C, Lantry AM, Marion M, et al. Chronic Co-administration of Methylphenidate and Fluoxetine Reduces Striatal NMDA Receptor Binding in Adolescent Rats. Neurochemical Research. 2026;51(2). doi:10.1007/s11064-026-04743-5
BibTeX
@article{Lagamjis2026,
author = {Lagamjis, George and Slayton, Divon and Lu, Huy and Hoerner, Caleigh and Lantry, Abigail M and Marion, Matthew and Elman, Dan and Hadjiargyrou, Michael and Komatsu, David and Thanos, Panayotis K},
title = {Chronic Co-administration of Methylphenidate and Fluoxetine Reduces Striatal NMDA Receptor Binding in Adolescent Rats},
journal = {Neurochemical Research},
year = {2026},
volume = {51},
number = {2},
doi = {10.1007/s11064-026-04743-5}
}
EUVIMED